Foghorn Therapeutics Ratios (2020-2025) | FHTX

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -10,441.90%-8,406.37%-8,257.34%-8,514.70%-65,268.29%-3,998.32%-686.58%-608.31%-388.44%-690.39%-563.72%-509.82%-77.85%-383.43%-495.37%-333.61%-244.90%-682.88%-339.73%-248.62%-202.00%
EBIT Margin -10,329.05%-8,278.49%-8,087.41%-8,337.28%-64,051.22%-3,938.57%-709.29%-650.07%-425.97%-762.09%-627.56%-572.42%-97.73%-441.29%-558.30%-386.64%-305.48%-840.51%-384.96%-279.17%-226.92%
EBITDA Margin -10,260.89%-8,272.91%-8,032.52%-8,289.25%-63,617.07%-4,086.96%-716.79%-652.74%-413.69%-669.41%-553.25%-523.95%-77.35%-399.36%-488.85%-331.30%-235.96%-690.76%-318.46%-238.11%-193.56%
Operating Margin -10,329.05%-8,278.49%-8,087.41%-8,337.28%-64,051.22%-3,938.57%-709.29%-650.07%-425.97%-762.09%-627.56%-572.42%-97.73%-441.29%-558.30%-386.64%-305.48%-840.51%-384.96%-279.17%-226.92%
Net Margin -10,441.90%-8,406.37%-8,257.34%-8,514.70%-65,268.29%-3,998.32%-686.58%-608.31%-388.44%-690.39%-574.27%-526.65%-82.07%-417.85%-495.37%-333.61%-244.90%-682.88%-339.73%-248.62%-202.00%
FCF Margin -1,507.82%-7,228.69%-8,720.63%-7,058.06%-50,565.85%1,655.26%6,920.59%-654.25%-306.24%-697.73%-599.28%-583.03%-156.15%-478.04%-583.09%-370.99%-272.98%-875.28%-403.16%-278.18%-231.33%
Efficiency
Assets Average 199.01M242.74M219.21M197.30M352.92M504.04M472.60M445.42M419.41M388.88M356.23M326.50M299.67M270.46M291.79M318.48M296.18M271.34M242.46M215.60M
Equity Average -108.81M-124.87M6.43M135.68M114.68M92.59M88.93M84.64M60.02M35.98M12.22M-12.24M-36.97M-53.37M-67.29M-87.34M-55.90M-21.30M-36.91M-53.59M-69.16M-83.16M
Invested Capital -101.20M-116.41M-127.33M165.84M144.90M124.02M100.90M96.87M72.40M47.63M24.32M0.11M-24.59M-49.35M-57.39M-77.19M-97.49M-14.32M-28.29M-45.53M-61.65M-76.66M-89.66M
Asset Utilization Ratio 0.000.000.000.000.000.010.020.040.050.050.060.100.110.130.120.080.080.090.100.11
Leverage & Solvency
Interest Coverage Ratio -53.19-78.48-91.53-64.73-47.59-46.99-52.63-65.92
Debt to Equity -0.110.13
Debt Ratio 0.100.08
Equity Ratio -0.940.570.540.500.440.190.150.100.060.00-0.07-0.15-0.18-0.27-0.38-0.04-0.09-0.16-0.24-0.34-0.44
Times Interest Earned -53.19-78.48-91.53-64.73-47.59-46.99-52.63-65.92
Valuation
Enterprise Value -3.44M-36.56M-75.16M-92.80M-66.45M-125.17M-57.84M-101.14M-213.65M-61.21M-87.63M-52.21M-50.64M-57.70M-70.31M-80.34M-79.25M-138.95M-57.68M-55.45M-61.03M-73.82M-90.58M
Return Ratios
Return on Sales -104.42%-84.06%-82.57%-85.15%-652.68%-39.98%-6.87%-6.08%-3.88%-6.90%-5.74%-5.27%-0.82%-4.18%-4.95%-3.34%-2.45%-6.83%-3.40%-2.49%-2.02%
Return on Capital Employed -0.38%-0.34%-0.42%-0.52%-0.33%-0.23%-0.26%-0.29%-0.32%-0.37%-0.42%-0.42%-0.45%-0.47%-0.40%-0.40%-0.45%-0.49%-0.56%-0.66%
Return on Invested Capital 10.07%3.44%2.19%1.68%1.23%1.80%5.00%
Return on Assets -0.35%-0.33%-0.40%-0.48%-0.29%-0.21%-0.23%-0.24%-0.26%-0.29%-0.32%-0.32%-0.33%-0.34%-0.30%-0.29%-0.29%-0.30%-0.32%-0.35%
Return on Equity -10.81%-0.58%-0.76%-1.03%-1.15%-1.25%-1.82%-3.02%-8.91%9.19%3.10%1.93%1.46%1.06%1.55%4.28%2.35%1.53%1.12%0.90%